Petrus Bekker, Chief Medical Officer at ChemoCentryx, Inc. (CCXI), sold 1,250 shares at $8.30 ($10K) on 2016-11-22, disclosed to the SEC on 2016-11-23.
Scheduled sale ($10k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CCXI | SELL | 2017-06-30 | $760K | — | Filing → |
| CCXI | SELL | 2016-12-20 | $134K | — | Filing → |
| CCXI | SELL | 2016-12-07 | $255K | — | Filing → |